Nutritional Therapy in Patients With Post-extubation Dysphagia
NCT ID: NCT06511284
Last Updated: 2024-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
128 participants
INTERVENTIONAL
2024-07-01
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Outcomes Between Parenteral and Enteral Nutrition
NCT02512224
The Effect of Parenteral Nutrition Supplement on Esophagectomy Patients
NCT01669356
Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer Patient
NCT01952210
Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and Survival
NCT03676478
Evaluation Of The Effectiveness Of Safe Nutrition Program Applied To Acute Stroke Patients With Dysphagia
NCT06269575
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High protein group
100% of the energy requirements measured by indirect calorimetry (IC) or estimated, and a protein intake of 2.0 g/kg, will be prescribed
High protein dose
High dose of protein (2.0 g/kg) will prescribed for home enteral nutrition
Usual protein group
100% of the energy requirements measured by IC or estimated, and a protein intake of 1.5 g/kg, will be prescribed.
Usual protein dose
Usual dose of protein (1.5 g/kg) will prescribed for home enteral nutrition
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High protein dose
High dose of protein (2.0 g/kg) will prescribed for home enteral nutrition
Usual protein dose
Usual dose of protein (1.5 g/kg) will prescribed for home enteral nutrition
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who discharged with a feeding tube.
* Patients with signed informed consent.
Exclusion Criteria
* Patients with chronic kidney disease, defined as a glomerular filtration rate \<60 ml/min.
* Patients discharged with a terminal condition and/or life expectancy of less than 3 months.
* Diagnosis of HIV, upon receiving clinical follow-up by the team of specialists.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Respiratory Diseases, Mexico
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ivan Armando Osuna Padilla
Clinical Nutrition Manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ivan A Osuna-Padilla, PhD
Role: PRINCIPAL_INVESTIGATOR
Instituto Nacional de Enfermedades Respiratorias
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Respiratory Diseases
Mexico City, , Mexico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C32-24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.